However, these events are but the immediate manifestation of a continuing dependent relationship that involves three types of interactions: licensing CBW drugs and biologics, especially vaccines; using Investigational New Drugs in military combat (and other special situations); and ensuring the compliance of producers with manufacturing requirements. DoD has not been well organized to respond to FDA. This report proposes various education and training programs that should be initiated for all defense personnel engaged in the development or acquisition of drugs and biologics for CBW defense. It also recommends organiza.
